Contact
Please use this form to send email to PR contact of this press release:
The WHO Recognizes NOX Inhibitors as New Therapeutic Class and Approves Setanaxib for GKT831
TO:
Please use this form to send email to PR contact of this press release:
The WHO Recognizes NOX Inhibitors as New Therapeutic Class and Approves Setanaxib for GKT831
TO: